-
161
-
162
JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
Published 2020-01-01“…The deposition of amyloid beta (Aβ) and tau hyperphosphorylation are hallmarks of AD and are major therapeutic targets. …”
Get full text
Article -
163
HHV-6A infection induces amyloid-beta expression and activation of microglial cells
Published 2019-12-01“…Abstract Background The control of viral infections in the brain involves the activation of microglial cells, the macrophages of the brain that are constantly surveying the central nervous system, and the production of amyloid-beta (Aβ) as an anti-microbial molecule. Recent findings suggest a possible implication of HHV-6A in AD. …”
Get full text
Article -
164
Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion
Published 2024-06-01“…Abstract Background Recent reports suggest that amyloid beta (Aβ) peptides can exhibit prion-like pathogenic properties. …”
Get full text
Article -
165
Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo
Published 2020-08-01“…Detection of amyloid beta deposits is often performed with fluorescent compounds that bind plaques. …”
Get full text
Article -
166
C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta
Published 2017-01-01“…Primary mouse neurons treated with both 100 nM C5a and 5 µM fibrillar amyloid beta (fAβ), to model what occurs in the AD brain, showed increased MAP-2 loss relative to either C5a or fAβ alone. …”
Get full text
Article -
167
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Published 2013-12-01“…Diana L Castillo-Carranza,1,2 Marcos J Guerrero-Muñoz,1,2 Rakez Kayed1–31Mitchell Center for Neurodegenerative Diseases, 2Departments of Neurology, Neuroscience, and Cell Biology, 3Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USAAbstract: Alzheimer's disease (AD) is characterized by the presence of amyloid plaques composed mainly of amyloid-β (Aβ) protein. Overproduction or slow clearance of Aβ initiates a cascade of pathologic events that may lead to formation of neurofibrillary tangles, neuronal cell death, and dementia. …”
Get full text
Article -
168
Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease.
Published 2024-07-01“…Reduction of amyloid beta (Aβ) has been shown to be effective in treating Alzheimer's disease (AD), but the underlying assumption that neurons are the main source of pathogenic Aβ is untested. …”
Get full text
Article -
169
Dichlorodiphenyltrichloroethane Impairs Amyloid Beta Clearance by Decreasing Liver X Receptor α Expression
Published 2021-05-01Subjects: “…amyloid beta…”
Get full text
Article -
170
A New Strategy in Epilepsy Therapy Through Attenuation of Phosphorylated Tau and Amyloid-beta
Published 2025-03-01Subjects: “…amyloid-beta peptides…”
Get full text
Article -
171
Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease
Published 2011-01-01“…Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. …”
Get full text
Article -
172
Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice.
Published 2012-01-01Get full text
Article -
173
Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
Published 2018-05-01Subjects: “…amyloid beta…”
Get full text
Article -
174
-
175
Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model
Published 2021-03-01“…Summary: Alzheimer’s disease is characterized by the deposition of extracellular amyloid-beta (Aβ) plaques. While microglial phagocytosis is a major mechanism through which Aβ is cleared, there is no method for quantitatively assessing Aβ phagocytic capacity of microglia in vivo. …”
Get full text
Article -
176
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression
Published 2019-06-01“…AD pathology hallmarks include accumulation of senile plaques and neurofibrillary tangles; however, evidence supports that soluble amyloid beta (Aβ), rather than insoluble plaques, may instigate synaptic failure. …”
Get full text
Article -
177
Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
Published 2022-10-01Subjects: Get full text
Article -
178
NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression.
Published 2013-01-01“…There is considerable evidence supporting the involvement of oligomeric amyloid-beta (Aβ) in the etiology of Alzheimer's disease. …”
Get full text
Article -
179
Verbenalin Reduces Amyloid-Beta Peptide Generation in Cellular and Animal Models of Alzheimer’s Disease
Published 2022-12-01Subjects: Get full text
Article -
180
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts
Published 2024-02-01Subjects: Get full text
Article